These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 22716152)

  • 1. Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studies.
    Rapp C; Bugra H; Riecher-Rössler A; Tamagni C; Borgwardt S
    Curr Pharm Des; 2012; 18(32):5070-80. PubMed ID: 22716152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis use and brain structural alterations of the cingulate cortex in early psychosis.
    Rapp C; Walter A; Studerus E; Bugra H; Tamagni C; Röthlisberger M; Borgwardt S; Aston J; Riecher-Rössler A
    Psychiatry Res; 2013 Nov; 214(2):102-8. PubMed ID: 24054726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study.
    Delvecchio G; Oldani L; Mandolini GM; Pigoni A; Ciappolino V; Schiena G; Lazzaretti M; Caletti E; Barbieri V; Cinnante C; Triulzi F; Brambilla P
    J Vis Exp; 2020 Aug; (162):. PubMed ID: 32894263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis use and brain structural alterations in first episode schizophrenia--a region of interest, voxel based morphometric study.
    Bangalore SS; Prasad KM; Montrose DM; Goradia DD; Diwadkar VA; Keshavan MS
    Schizophr Res; 2008 Feb; 99(1-3):1-6. PubMed ID: 18248793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cannabis and psychosis: search of a causal link through a critical and systematic review].
    Le Bec PY; Fatséas M; Denis C; Lavie E; Auriacombe M
    Encephale; 2009 Sep; 35(4):377-85. PubMed ID: 19748375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis-associated psychosis: Neural substrate and clinical impact.
    Murray RM; Englund A; Abi-Dargham A; Lewis DA; Di Forti M; Davies C; Sherif M; McGuire P; D'Souza DC
    Neuropharmacology; 2017 Sep; 124():89-104. PubMed ID: 28634109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential protective effects of cannabidiol on neuroanatomical alterations in cannabis users and psychosis: a critical review.
    Hermann D; Schneider M
    Curr Pharm Des; 2012; 18(32):4897-905. PubMed ID: 22716143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cannabis and psychosis--a review].
    Schaub M; Rössler W; Stohler R
    Praxis (Bern 1994); 2004 Jun; 93(23):997-1002. PubMed ID: 15233568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcortical grey matter alterations in cocaine dependent individuals with substance-induced psychosis compared to non-psychotic cocaine users.
    Willi TS; Lang DJ; Honer WG; Smith GN; Thornton AE; Panenka WJ; Procyshyn RM; Vila-Rodriguez F; Su W; Vertinsky AT; Leonova O; Rauscher A; MacEwan GW; Barr AM
    Schizophr Res; 2016 Oct; 176(2-3):158-163. PubMed ID: 27499362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological soft signs in patients with psychosis and cannabis abuse: a systematic review and meta-analysis of paradox.
    Ruiz-Veguilla M; Callado LF; Ferrin M
    Curr Pharm Des; 2012; 18(32):5156-64. PubMed ID: 22716154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis use and psychosis: theme introduction.
    Martinotti G; Di Iorio G; Sepede G; De Berardis D; De Risio L; Di Giannantonio M
    Curr Pharm Des; 2012; 18(32):4991-8. PubMed ID: 22716149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia.
    Szeszko PR; Robinson DG; Sevy S; Kumra S; Rupp CI; Betensky JD; Lencz T; Ashtari M; Kane JM; Malhotra AK; Gunduz-Bruce H; Napolitano B; Bilder RM
    Br J Psychiatry; 2007 Mar; 190():230-6. PubMed ID: 17329743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of cannabis use in psychosis].
    Pajkossy P; Demetrovics Z
    Psychiatr Hung; 2007; 22(2):145-62. PubMed ID: 17895537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis abuse and risk for psychosis in a prodromal sample.
    Kristensen K; Cadenhead KS
    Psychiatry Res; 2007 May; 151(1-2):151-4. PubMed ID: 17383738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cannabis and cannabinoid receptors--abuse and psychosis].
    Hjorthøj C; Nordentoft M; Fink-Jensen A
    Ugeskr Laeger; 2008 Nov; 170(46):3782-4. PubMed ID: 19014732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence.
    Malchow B; Hasan A; Fusar-Poli P; Schmitt A; Falkai P; Wobrock T
    Eur Arch Psychiatry Clin Neurosci; 2013 Feb; 263(1):3-13. PubMed ID: 22907121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis and psychosis: have we found the missing links?
    Parakh P; Basu D
    Asian J Psychiatr; 2013 Aug; 6(4):281-7. PubMed ID: 23810133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-environment interactions underlying the effect of cannabis in first episode psychosis.
    Pelayo-Terán JM; Suárez-Pinilla P; Chadi N; Crespo-Facorro B
    Curr Pharm Des; 2012; 18(32):5024-35. PubMed ID: 22716151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cannabis and psychoses].
    Kristensen FW
    Ugeskr Laeger; 1994 May; 156(19):2875-8, 2881. PubMed ID: 8009723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults.
    Cohen M; Rasser PE; Peck G; Carr VJ; Ward PB; Thompson PM; Johnston P; Baker A; Schall U
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):297-307. PubMed ID: 21557880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.